The needle-free Glucowear continuous glucose monitor (CGM) has recently been exhibited at the American Diabetes Association’s 83rd Scientific Sessions and has also had an impressive design overhaul. The non-invasive Glucowear blood sugar tracker could seriously disrupt the current diabetes device market if Afon manages to start selling it in 2024.